• Medientyp: E-Artikel
  • Titel: A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia
  • Beteiligte: Kos, Renate; Goutaki, Myrofora; Kobbernagel, Helene E.; Rubbo, Bruna; Shoemark, Amelia; Aliberti, Stefano; Altenburg, Josje; Anagnostopoulou, Pinelopi; Athanazio, Rodrigo A.; Beydon, Nicole; Dell, Sharon D.; Emiralioglu, Nagehan; Ferkol, Thomas W.; Loebinger, Michael R.; Lorent, Natalie; Maître, Bernard; Marthin, June; Morgan, Lucy C.; Nielsen, Kim G.; Ringshausen, Felix C.; Shteinberg, Michal; Tiddens, Harm A.W.M.; Maitland-Van der Zee, Anke H.; Chalmers, James D.; [...]
  • Erschienen: European Respiratory Society (ERS), 2024
  • Erschienen in: ERJ Open Research, 10 (2024) 1, Seite 00115-2023
  • Sprache: Englisch
  • DOI: 10.1183/23120541.00115-2023
  • ISSN: 2312-0541
  • Schlagwörter: Pulmonary and Respiratory Medicine
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: BackgroundConsistent use of reliable and clinically appropriate outcome measures is a priority for clinical trials, with clear definitions to allow comparability. We aimed to develop a core outcome set (COS) for pulmonary disease interventions in primary ciliary dyskinesia (PCD).MethodsA multidisciplinary international PCD expert panel was set up. A list of outcomes was created based on published literature. Using a modified three-round e-Delphi technique, the panel was asked to decide on relevant end-points related to pulmonary disease interventions and how they should be reported. First, inclusion of an outcome in the COS was determined. Second, the minimum information that should be reported per outcome. The third round finalised statements. Consensus was defined as ≥80% agreement among experts.ResultsDuring the first round, experts reached consensus on four out of 24 outcomes to be included in the COS. Five additional outcomes were discussed in subsequent rounds for their use in different subsettings. Consensus on standardised methods of reporting for the COS was reached. Spirometry, health-related quality-of-life scores, microbiology and exacerbations were included in the final COS.ConclusionThis expert consensus resulted in a COS for clinical trials on pulmonary health among people with PCD.
  • Zugangsstatus: Freier Zugang